Recent Australian research conducted as part of the international effort, identified 48 previously unknown genes that affect the

Dr Brian Chambers and colleagues at the Austin Hospital, Melbourne, have published further findings from their MS Research

An international team of scientists including a strong Australian contingent has made a key discovery in new research

A landmark genetics paper published today has identified 48 new genes involved in the risk of developing MS.

The European Medicines Agency yesterday approved alemtuzumab (Lemtrada) for relapsing remitting MS. Alemtuzumab is an intravenous infusion drug

Researchers have used proteomic profiling to characterise stages and severity of MS, in an attempt to provide new

Recent months have seen further publication of the findings from ongoing research into chronic cerebrospinal venous insufficiency (CCSVI)